Strategies to Reduce Addiction Stigma Among Health Professionals
Effect of Exposure to Visual Campaigns and Narrative Vignettes on Addiction Stigma Among Health Professionals: A Randomized Experiment
1 other identifier
interventional
1,842
1 country
1
Brief Summary
The aim of this study was to evaluate the effects of exposure to stigma reduction message frames communicated by visual campaigns and narrative vignettes among a national sample of health professionals.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Nov 2020
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 13, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 30, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
November 30, 2020
CompletedFirst Submitted
Initial submission to the registry
October 28, 2021
CompletedFirst Posted
Study publicly available on registry
November 19, 2021
CompletedNovember 19, 2021
November 1, 2021
17 days
October 28, 2021
November 8, 2021
Conditions
Outcome Measures
Primary Outcomes (6)
Rating of willingness to have person with opioid use disorder marry into their family
Item from the Social Distance Scale that measures one element of stigma (desire for social distance). Measured on 5-point Likert scale with 5 indicating greater unwillingness and 1 indicating greater willingness to have a person with opioid use disorder marry into the family. Measured via survey questionnaire.
Measured immediately post-exposure to message frame intervention
Rating of willingness to have person with opioid use disorder as a neighbor
Item from the Social Distance Scale that measures one element of stigma (desire for social distance). Measured on 5-point Likert scale with 5 indicating greater unwillingness and 1 indicating greater willingness to have a person with opioid use disorder as a neighbor. Measured via survey questionnaire.
Measured immediately post-exposure to message frame intervention
Rating of agreement that opioid use disorder is a medical condition
Rating of agreement with statement "Opioid use disorder is a chronic medical condition like diabetes mellitus" on 5-point Likert scale with 5 indicating strong disagreement and 1 indicating strong agreement. Measured via survey questionnaire.
Measured immediately post-exposure to message frame intervention
Rating of agreement that individuals with opioid use disorder are to blame
Rating of agreement with statement "Individuals with opioid use disorder only have themselves to blame for their problem" on 5-point Likert scale with 5 indicating strong disagreement and 1 indicating strong agreement. Measured via survey questionnaire.
Measured immediately post-exposure to message frame intervention
Rating of support for increasing government spending on opioid use disorder treatment
Rating of support for increasing government spending on treatment of opioid use disorder with 5 indicating strongly favoring and 1 indicating strongly opposing. Measured via survey questionnaire.
Measured immediately post-exposure to message frame intervention
Feeling thermometer measure of warmth toward people with opioid use disorder
Rating of warmth felt toward people with opioid use disorder with 0 indicating extremely cold and 100 indicating extremely warm. Measured via survey questionnaire.
Measured immediately post-exposure to message frame intervention
Secondary Outcomes (17)
Stigmatizing Language - Addict
Measured immediately post-exposure to message frame intervention
Stigmatizing Language - Substance abuse
Measured immediately post-exposure to message frame intervention
Stigmatizing Language - dirty
Measured immediately post-exposure to message frame intervention
Stigmatizing Language - clean
Measured immediately post-exposure to message frame intervention
Stigmatizing Language - addicted baby
Measured immediately post-exposure to message frame intervention
- +12 more secondary outcomes
Study Arms (9)
No exposure control group
NO INTERVENTIONThis group was not exposed to any message frame.
Words Matter - Visual Campaign
EXPERIMENTALParticipants randomized to this arm were exposed to a visual campaign communicating the importance of use of non-stigmatizing language regarding substance use disorder and opioid use disorder in clinical settings.
Words Matter - Visual Campaign & Narrative Vignette (Messenger: Person with Opioid Use Disorder)
EXPERIMENTALParticipants randomized to this arm were exposed to a visual campaign communicating the importance of use of non-stigmatizing language regarding substance use disorder and opioid use disorder in clinical settings and a narrative vignette told from the perspective of a person with opioid use disorder.
Words Matter - Visual Campaign & Narrative Vignette (Messenger: Clinician)
EXPERIMENTALParticipants randomized to this arm were exposed to a visual campaign communicating the importance of use of non-stigmatizing language regarding substance use disorder and opioid use disorder in clinical settings and a narrative vignette told from the perspective of a clinician.
Words Matter - Visual Campaign & Narrative Vignette (Messenger: Health System Administrator)
EXPERIMENTALParticipants randomized to this arm were exposed to a visual campaign communicating the importance of use of non-stigmatizing language regarding substance use disorder and opioid use disorder in clinical settings and a narrative vignette told from the perspective of a health system administrator/leader.
Medication Treatment Works - Visual Campaign
EXPERIMENTALParticipants randomized to this arm were exposed to a visual campaign communicating the effectiveness of medications for treating opioid use disorder in saving lives.
Medication Treatment Works - Visual Campaign & Narrative Vignette (Person with OUD)
EXPERIMENTALParticipants randomized to this arm were exposed to a visual campaign communicating the effectiveness of medications for treating opioid use disorder in saving lives and a narrative vignette told from the perspective of a person with opioid use disorder.
Medication Treatment Works - Visual Campaign & Narrative Vignette (Clinician)
EXPERIMENTALParticipants randomized to this arm were exposed to a visual campaign communicating the effectiveness of medications for treating opioid use disorder in saving lives and a narrative vignette told from the perspective of a clinician.
Medication Treatment Works - Visual Campaign & Narrative Vignette (Health System Administrator)
EXPERIMENTALParticipants randomized to this arm were exposed to a visual campaign communicating the effectiveness of medications for treating opioid use disorder in saving lives and a narrative vignette told from the perspective of a health system administrator/leader.
Interventions
Visual campaign emphasizing the importance of using non-stigmatizing language related to substance use and opioid use disorder in clinical settings.
Visual campaign emphasizing the importance of using non-stigmatizing language related to substance use and opioid use disorder in clinical settings combined with a narrative vignette told from the perspective of a person with opioid use disorder
Visual campaign emphasizing the importance of using non-stigmatizing language related to substance use and opioid use disorder in clinical settings combined with a narrative vignette told from the perspective of a clinician working with patients with opioid use disorder
Visual campaign emphasizing the importance of using non-stigmatizing language related to substance use and opioid use disorder in clinical settings combined with a narrative vignette told from the perspective of a health system administrator/leader
Visual campaign emphasizing the effectiveness and value of medications to treat opioid use disorder in saving lives
Visual campaign emphasizing the effectiveness and value of medications to treat opioid use disorder in saving lives combined with a narrative vignette told from the perspective of a person with opioid use disorder
Visual campaign emphasizing the effectiveness and value of medications to treat opioid use disorder in saving lives combined with a narrative vignette told from the perspective of a clinician who treats people with opioid use disorder
Visual campaign emphasizing the effectiveness and value of medications to treat opioid use disorder in saving lives combined with a narrative vignette told from the perspective of a health system administrator/leader
Eligibility Criteria
You may qualify if:
- employed as health professional in the United States, including clinicians (e.g., physicians, nurses, physician assistants, pharmacists, and optometrists), technicians and technologists (e.g., laboratory technologist or technician, emergency medical technician, paramedic, licensed practical or licensed vocational nurse, medical records or health information technician, etc.), health aids and assistants (e.g., nursing aide, home health aide, medical assistant, pharmacy aide, phlebotomist, etc.)
- participant in existing web-based survey panel (IPSOS's KnowledgeNetworks panel and partner opt-in panel)
You may not qualify if:
- not employed in health profession
- not able to complete experiment and survey in English
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Johns Hopkins Bloomberg School of Public Health
Baltimore, Maryland, 21205, United States
Related Publications (1)
Kennedy-Hendricks A, McGinty EE, Summers A, Krenn S, Fingerhood MI, Barry CL. Effect of Exposure to Visual Campaigns and Narrative Vignettes on Addiction Stigma Among Health Care Professionals: A Randomized Clinical Trial. JAMA Netw Open. 2022 Feb 1;5(2):e2146971. doi: 10.1001/jamanetworkopen.2021.46971.
PMID: 35119460DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Alene Kennedy-Hendricks, PhD
Johns Hopkins Bloomberg School of Public Health
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- OTHER
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
October 28, 2021
First Posted
November 19, 2021
Study Start
November 13, 2020
Primary Completion
November 30, 2020
Study Completion
November 30, 2020
Last Updated
November 19, 2021
Record last verified: 2021-11
Data Sharing
- IPD Sharing
- Will not share